Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02105779 · ClinicalTrials.gov registry record · NA
Optimizing Cognitive Remediation Outcomes in Schizophrenia
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 172
- Enrollment target
NCT02105779 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 172 participants.
The verdict
NCT02105779, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 172 participants
- Enrollment target
Study Summary
The purpose of this study is to drive an optimal response to neuroplasticity-based cognitive remediation in schizophrenia in order to maximize treatment response. The investigators will investigate factors that have generally been ignored in prior computer-based cognitive remediation programs-those related to social cognition-- and will delineate their relationship to motivation, functional outcome, and the neural substrates of reward anticipation and emotion processing. Current research indicates that, unless the investigators fully understand and harness these factors, the investigators will not achieve meaningful treatment gains for individuals with schizophrenia.
Interventions
- OTHER Targeted Cognitive Training
- OTHER Social Cognitive Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2009-12 |
| Est. Completion | 2016-07-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02105779
The ClinicalTrials.gov registry entry for NCT02105779 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 172 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Targeted Cognitive Training is the first listed.
NCT02105779 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02105779 about?
NCT02105779 is a clinical study titled "Optimizing Cognitive Remediation Outcomes in Schizophrenia". The purpose of this study is to drive an optimal response to neuroplasticity-based cognitive remediation in schizophrenia in order to maximize treatment response. The investigators will investigate factors that have generally been ignored in prior computer-based cognitive remediation programs-those ...
What is the current status of trial NCT02105779?
This trial is currently completed. It is a NA study. The enrollment target is 172 participants. The study started on 2009-12. Estimated completion is 2016-07-26.
What interventions are being tested in trial NCT02105779?
The interventions under investigation include: Targeted Cognitive Training (OTHER), Social Cognitive Training (OTHER).
Who is sponsoring clinical trial NCT02105779?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.